OPK · Opko Health, Inc. · Executive Compensation
$1.66
+0.05 (+2.96%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$1.20B
Shares
746.33M
Volume · Oct 20
4.31M
Avg daily vol (3M)
4.23M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jon R. Cohen | Senior Vice President-OPKO | $3,434,600 |
| Adam Logal | Senior Vice President and Chief Financial Officer | $1,902,100 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jon R. Cohen | Senior Vice President-OPKO | $3,491,200 |
| Adam Logal | Senior Vice President and Chief Financial Officer | $1,552,200 |
| Phillip Frost | Chief Executive Officer | $1,538,200 |
| Jane H. Hsiao | Chief Technical Officer | $1,478,200 |
| Steven D. Rubin | Executive Vice President- Administration | $1,262,200 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jon R. Cohen | Senior Vice President-OPKO | $2,297,200 |
| OPKO Health | Inc.; Executive Chairman-BioReference Health, LLC | $2,297,200 |
| Phillip Frost | Chief Executive Officer | $1,405,200 |
| Jane H. Hsiao | Chief Technical Officer | $1,345,200 |
| Steven D. Rubin | Executive Vice President- Administration | $1,131,200 |
| Adam Logal | Senior Vice President and Chief Financial Officer | $921,200 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Phillip Frost | Chief Executive Officer | $2,036,000 |
| Jane H. Hsiao | Chief Technical Officer | $1,976,000 |
| Steven D. Rubin | Executive Vice President- Administration | $1,460,000 |
| Adam Logal | Senior Vice President and Chief Financial Officer | $1,250,000 |
| OPKO Health | Inc.; Executive Chairman-BioReference Laboratories, Inc. | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Phillip Frost | Chief Executive Officer | $970,800 |
| Jane H. Hsiao | Chief Technical Officer | $915,800 |
| Adam Logal | Senior Vice President and Chief Financial Officer | $610,800 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Subbarao V. Uppaluri | new director | Appointed | 2026-03-19 |
| Jon R. Cohen | member of the Board of Directors | Retired | 2022-08-16 |
| Jon R. Cohen | Senior Vice President | Retired | 2022-08-16 |
| Jon R. Cohen | Executive Chairman and Chief Executive Officer of BioReference | Retired | 2022-08-16 |
| Jon R. Cohen | Executive Chairman and Chief Executive Officer of BioReference | Retired | 2022-08-16 |
Leadership
- Phillip Frost CEO
- Elias Zerhouni, M.D. Chairman
- OPKO Health Chairman
- Adam Logal CFO
- Gary Nabel, M.D., Ph.D. CIO, Board Member
- Rulfo Hernandez Chief Accounting Officer
- Alexis Borisy Board Member
- Anthony Japour, M.D. Board Member
- Jon R. Cohen, M.D. Board Member
- Prem A. Lachman, M.D. Board Member
- Roger J. Medel, M.D. Board Member
- Subbarao V. Uppaluri Board Member
- Subbarao V. Uppaluri, Ph.D. Board Member
Key facts
CIK
944809
CUSIP
68375N103
13F (30d)
17 filings
17 filers
Visit website
Investor relations